• The claim that COVID-19 vaccines increase the risk of herpes‑zoster meningitis by 1,200 times compared with flu shots is not supported by any peer‑reviewed study or verified fact‑check.
• A systematic review and meta‑analysis found that mRNA COVID‑19 vaccines were associated with only a roughly 1.5‑ to 2‑fold increased reporting of herpes zoster compared with influenza vaccines (ROR 1.9 overall, 1.5–2.0 by vaccine type), not a 1,200‑fold increase¹.
• Large cohort studies with proper controls report adjusted hazard ratios for herpes zoster of only about 1.12–1.18 after mRNA COVID‑19 vaccination versus unvaccinated individuals, and some analyses found COVID‑19 vaccination was not associated with a higher risk than influenza vaccination (HR 0.78–0.89)²³.
• A systematic review of meningitis after COVID‑19 vaccination identified only 35 total cases from 33 articles globally, with VZV as the most frequent viral pathogen, indicating the condition is extremely rare and not subject to a massive population‑level risk increase⁴.
• The 1,200‑times figure appears to follow the same pattern as previously debunked claims that misrepresented raw passive reporting counts or disproportionality ratios from systems like VAERS as actual risk measures, without accounting for doses administered, reporting bias, or causality⁵.

Overall validity: 0%

1. Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis - PMC
2. Neurologic complications of vaccination
3. Risk of herpes zoster following mRNA COVID-19 vaccine administration
4. Meningitis after COVID-19 vaccination, a systematic review of case reports and case series - PMC
5. Misleading to say brain clots '112000% more likely' after ... - AAP